GROW Group

18/12/2025

Come to the GROW Christmas Party with us! 🎄🍪

Last week, GROW® Group team members travelled in from across the UK and the world. We shared a beautiful lunch, took on a very serious (and very fun) spy mission game, enjoyed plenty of drinks, and had the chance to properly catch up.

It was the perfect moment to reflect on just how fantastic and rewarding this year has been. We are incredibly proud of the whole team, and grateful for the people who make GROW what it is.

Here’s to an even bigger year ahead. We can’t wait to see what next year brings ✨🎄

16/12/2025

08/12/2025

🌍 GROW is proud to have a global footprint. From Europe to Australia to Canada, we’re committed to expanding access, strengthening partnerships, and supporting patients worldwide.
 
Our mission is to create a world where life-changing CBMPs are obtainable to every patient who will benefit from them.
 

03/12/2025

On the 3rd of December, the International Day of Persons with Disabilities invites us to listen, learn, and appreciate the diverse experiences that shape the journeys of disabled people.

Some might have conditions that are visible, whilst others we may not be able to see. Approaching the experiences of others with curiosity, empathy and openness helps us all better understand and appreciate the stories they choose to share 💙

10/10/2025

Have you experienced stigma or discrimination for your prescription? This we're highlighting the misunderstanding and judgement that some patients face when using medicines prescribed for mental health conditions.

At GROW, we believe that everyone deserves compassion and respect for their healthcare choices. Let's challenge stigma, and choose empathy.

15/08/2025

🇫🇷 Big news from France! Plans are in motion to fully integrate MC into the national healthcare system — covering oils, capsules, and vaporisers.
 
The proposed regulations have already cleared the EU’s required review period and are now with the Conseil d’État (State Council) for final legal checks. If approved, this could mark a major milestone in patient access across the country 🌱

Source:
 

28/06/2025

Before the 30th of June, make sure to do your bit to oppose these benefit changes in the U.K. 🇬🇧

The Welfare bill would result in wide scale negative impact for disabled people, with MC patients being affected as many use PIP to pay for treatments. Even with the proposed changes, this bill may result in deaths that could have been prevented.

Check the link on our stories for a template to write to your MP, do your own research into the changes, and use your voice.

20/05/2025

PIP is a disability benefit which helps individuals with the extra costs associated with their disability, regardless of whether they are employed or not 🙏

have calculated the average household cost associated with disability in the U.K., which is £1,010 per month. This can be viewed in their 2024 "Disability Price Tag" report.

25/04/2025

Here's where you can find the GROW Team over the coming months! To arrange a face-to-face meeting, please get in contact via hello@growgroupplc.com 🌱

🇩🇪 Next week (29-30th April): Meet GROW® Deutschland GmbH, GROW® Pharma and GROW® Group PLC at the InternationalCBC in Berlin.

🏴󠁧󠁢󠁷󠁬󠁳󠁿 3-5th June: Team GROW® Group UK will be attending the The British Pain Society Annual Scientific Meeting.

🇩🇪 19-22nd June: GROW® Deutschland GmbH will be at this year's Mary Jane Berlin!

🇬🇧 25-26th June: You can find us at C*nnabis Europa 👏

16/04/2025

All of our GROW team have a unique passion for the plant and medical access ✊

Today we're spotlighting the talented Paddy Johnson and his motivations for working in the industry. Keep reading to learn about the experience he brings to the team!

01/04/2025

📣👏From today, GPs in the Czech Republic will be able to prescribe CBMPs – both for the treatment of chronic pain and as support for cancer and other serious illnesses. Until now, only 250 specialised Doctors were authorised to do so.

Limited prescribing by specialists is still the case in the UK. The have developed the Protect Our Patients campaign to achieve GP prescribing- visit their page to get involved 🇬🇧

20/03/2025

Australia has seen an extraordinary rise in total patients over the past five years, growing from just 18,000 in 2019 to a staggering 1 million in 2024.
 
This exponential increase reflects the expanding acceptance, accessibility, and awareness of MC as a treatment option. As regulations evolve and more patients seek alternative therapies, Australia continues to establish itself as a key player in the global MC landscape.
 
Source: Australian Health Practitioner Regulation Agency.